Sequenom Patent For Prenatal DNA Test Invalidated

Law360, New York (October 31, 2013, 4:38 PM EDT) -- A California federal judge on Wednesday struck down a patent covering a prenatal DNA test licensed to Sequenom Inc., relying on a slew of decisions by the U.S. Supreme Court holding that naturally occurring phenomena are not patentable, giving a win to accused infringer Ariosa Diagnostics Inc.

In a 20-page decision, U.S. District Judge Susan Illston determined that the Sequenom patent does little more than add established, routine scientific procedures to cell-free fetal DNA, or cffDNA. Because the naturally occurring cffDNA is the only innovative portion...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.